Baseline Requirements for Novel Agents Being Considered for Phase II/III Brain Cancer Efficacy Trials:Conclusions from the Adult Brain Tumor Consortium's First Workshop on CNS Drug Delivery.
暂无分享，去创建一个
J. Sarkaria | P. Wen | R. Bindra | M. Rudek | J. Supko | S. Grossman | L. Nabors | X. Ye | B. Ellingson | F. Barker | W. Timmer | W. Elmquist | D. Kamson | D. Peereboom | J. Fisher | C. Romo | P. Wen | S. Grossman | Fred G Barker | Carlos Romo